|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 2104501 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07862806.2 |
| Europos patento paraiškos padavimo data | 2007-12-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-09-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/025398 |
| Data | 2007-12-11 |
| (87) | Numeris | WO 2008/076278 |
| Data | 2008-06-26 |
| (30) | Numeris | Data | Šalis |
| 874589 P | 2006-12-13 | US | |
| 870937 P | 2006-12-20 | US | |
| 946011 P | 2007-06-25 | US | |
| 979274 P | 2007-10-11 | US |
| (72) |
WANG, Yan, US
ZONG, Chen, US
SEIDEL-DUGAN, Cynthia, US
WANG, Yaolin, US
YAO, Siu-long, US
LU, Brian Der-hua, US
LADHA, Mohamed H., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | METHODS OF CANCER TREATMENT WITH IGF1R INHIBITORS |
| METHODS OF CANCER TREATMENT WITH IGF1R INHIBITORS |